Loading clinical trials...
Loading clinical trials...
Grading of gliomas is of significant clinical importance since the prognosis as well as the treatment of choice are distinct in low-grade and high-grade gliomas. With standard MRI modalities, however,...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Turku University Hospital
NCT05099003 · Malignant Glioma
NCT05278208 · High Grade Glioma, Meningioma, and more
NCT07042620 · Brain Tumor Adult, Low Grade Glioma (LGG), High Grade Glioma (HGG), and more
NCT05717153 · Diffuse Glioma, Malignant Glioma
NCT02509442 · Low Grade Glioma of Brain
Turku University Hospital
Turku
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions